29Jun 07
Sanofi pulls obesity drug application in U.S. (Reuters)
Reuters - Sanofi-Aventis SA is withdrawing its
application to sell obesity drug rimonabant -- its biggest new
drug hope -- in the United States, the French drugmaker said on
Friday.
